| scholarly article | Q13442814 |
| P50 | author | Julio Altamirano | Q51729174 |
| Perla Pérez-Treviño | Q62587743 | ||
| P2093 | author name string | Noemí García | |
| Jorge Pérez-Treviño | |||
| Héctor Hernández-De la Cerda | |||
| Oscar Raúl Fajardo-Ramírez | |||
| P2860 | cites work | Affinity and avidity in antibody-based tumor targeting | Q24613552 |
| Comprehensive molecular portraits of human breast tumours | Q24630844 | ||
| Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors | Q27023623 | ||
| Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State. | Q27300459 | ||
| Affibody-DyLight conjugates for in vivo assessment of HER2 expression by near-infrared optical imaging | Q27333491 | ||
| Fiji: an open-source platform for biological-image analysis | Q27860912 | ||
| Generation of multicellular tumor spheroids of breast cancer cells: how to go three-dimensional | Q39189701 | ||
| Affibody Molecules in Biotechnological and Medical Applications | Q39313405 | ||
| The Expression Patterns of ER, PR, HER2, CK5/6, EGFR, Ki-67 and AR by Immunohistochemical Analysis in Breast Cancer Cell Lines | Q39669204 | ||
| Cell lines as candidate reference materials for quality control of ERBB2 amplification and expression assays in breast cancer | Q39851253 | ||
| Confocal mosaicing microscopy of human skin ex vivo: spectral analysis for digital staining to simulate histology-like appearance. | Q39993183 | ||
| In vivo single molecular imaging and sentinel node navigation by nanotechnology for molecular targeting drug-delivery systems and tailor-made medicine | Q40117166 | ||
| The growth and metastasis of human, HER-2/neu-overexpressing tumor cell lines in male SCID mice | Q40857892 | ||
| Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer | Q40991516 | ||
| Quantitative three-dimensional evaluation of immunofluorescence staining for large whole mount spheroids with light sheet microscopy. | Q41819606 | ||
| Molecular mapping of tumor heterogeneity on clinical tissue specimens with multiplexed quantum dots | Q41881092 | ||
| High-content analysis of tumour cell invasion in three-dimensional spheroid assays | Q42353637 | ||
| Feasibility of confocal fluorescence microscopy for real-time evaluation of neoplasia in fresh human breast tissue | Q45384515 | ||
| A meta-analysis on concordance between immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) to detect HER2 gene overexpression in breast cancer | Q45782977 | ||
| Small-Protein-Stabilized Semiconductor Nanoprobe for Targeted Imaging of Cancer Cells. | Q51353652 | ||
| Isolation and characterization of multipotent skin-derived precursors from human skin. | Q52048827 | ||
| Biodistribution and Radiation Dosimetry of the Anti-HER2 Affibody Molecule 68Ga-ABY-025 in Breast Cancer Patients. | Q52984700 | ||
| First-in-human molecular imaging of HER2 expression in breast cancer metastases using the 111In-ABY-025 affibody molecule. | Q53073318 | ||
| Co-culture of 3D tumor spheroids with fibroblasts as a model for epithelial-mesenchymal transition in vitro. | Q53841047 | ||
| Quantum dots-based double-color imaging of HER2 positive breast cancer invasion. | Q54587712 | ||
| Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update | Q57130157 | ||
| Specificity of HercepTest in determining HER-2/neu status of breast cancers using the United States Food and Drug Administration-approved scoring system | Q73181576 | ||
| HER2 testing by local, central, and reference laboratories in specimens from the North Central Cancer Treatment Group N9831 intergroup adjuvant trial | Q79816337 | ||
| Quantum-dot-based immunofluorescent imaging of HER2 and ER provides new insights into breast cancer heterogeneity | Q82684231 | ||
| Three-Dimensional Cell Cultures in Drug Discovery and Development | Q88098314 | ||
| Escalating and de-escalating treatment in HER2-positive early breast cancer | Q28069895 | ||
| The role and impact of quantitative discovery pathology | Q28295688 | ||
| Cellular effects of HER3-specific affibody molecules | Q28727774 | ||
| In situ protein expression in tumour spheres: development of an immunostaining protocol for confocal microscopy | Q30493990 | ||
| Tumor imaging using a picomolar affinity HER2 binding affibody molecule | Q33240101 | ||
| In vivo real-time tracking of single quantum dots conjugated with monoclonal anti-HER2 antibody in tumors of mice | Q33272403 | ||
| Trastuzumab-Induced Cardiotoxicity: Clinical and Prognostic Implications of Troponin I Evaluation | Q33647686 | ||
| Accounting for pharmacokinetic differences in dual-tracer receptor density imaging. | Q33688285 | ||
| Preclinical screening of anti-HER2 nanobodies for molecular imaging of breast cancer | Q33866799 | ||
| Quantifying cell-surface biomarker expression in thick tissues with ratiometric three-dimensional microscopy | Q34010353 | ||
| The role of HER2 in cancer therapy and targeted drug delivery | Q34054213 | ||
| Synthesis and Characterization of Anti-HER2 Antibody Conjugated CdSe/CdZnS Quantum Dots for Fluorescence Imaging of Breast Cancer Cells | Q34145580 | ||
| Integrating macrophages into organotypic co-cultures: a 3D in vitro model to study tumor-associated macrophages | Q34335849 | ||
| Affibody-based nanoprobes for HER2-expressing cell and tumor imaging | Q34545516 | ||
| Down-regulation of vitamin D receptor in mammospheres: implications for vitamin D resistance in breast cancer and potential for combination therapy | Q34558431 | ||
| Site-specifically conjugated anti-HER2 Affibody molecules as one-step reagents for target expression analyses on cells and xenograft samples | Q34596175 | ||
| Real-world performance of HER2 testing--National Surgical Adjuvant Breast and Bowel Project experience | Q34669824 | ||
| Influence of affinity and antigen internalization on the uptake and penetration of Anti-HER2 antibodies in solid tumors | Q34802043 | ||
| Confocal fluorescence microscopy for rapid evaluation of invasive tumor cellularity of inflammatory breast carcinoma core needle biopsies | Q34983629 | ||
| Spherical cancer models in tumor biology | Q35023931 | ||
| Assessment of different permeabilization methods of minimizing damage to the adherent cells for detection of intracellular RNA by flow cytometry | Q35093783 | ||
| Designing multifunctional quantum dots for bioimaging, detection, and drug delivery | Q35538371 | ||
| High-throughput imaging: Focusing in on drug discovery in 3D. | Q35853192 | ||
| In vivo quantification of tumor receptor binding potential with dual-reporter molecular imaging | Q36479293 | ||
| Trastuzumab-related cardiotoxicity in early breast cancer: a cohort study | Q37038459 | ||
| Comparison of the types of candidate reference samples for quality control of human epidermal growth factor receptor 2 status detection | Q37246183 | ||
| Fluorescence microscopy: a concise guide to current imaging methods | Q37247866 | ||
| The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine | Q37433324 | ||
| Near-infrared quantum dots for HER2 localization and imaging of cancer cells | Q37641853 | ||
| Affibody molecules: engineered proteins for therapeutic, diagnostic and biotechnological applications. | Q37730252 | ||
| HER2 testing: current status and future directions. | Q38147681 | ||
| Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer | Q38915097 | ||
| Spraying quantum dot conjugates in the colon of live animals enabled rapid and multiplex cancer diagnosis using endoscopy | Q38959803 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 3 | |
| P921 | main subject | quantum dot | Q1133068 |
| P304 | page(s) | 672-685 | |
| P577 | publication date | 2018-04-04 | |
| P1433 | published in | Translational Oncology | Q26839583 |
| P1476 | title | 3D Imaging Detection of HER2 Based in the Use of Novel Affibody-Quantum Dots Probes and Ratiometric Analysis. | |
| P478 | volume | 11 |
| Q64243443 | State-of-the-Art of Profiling Immune Contexture in the Era of Multiplexed Staining and Digital Analysis to Study Paraffin Tumor Tissues | cites work | P2860 |
Search more.